| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, and
Department of Pediatrics, Division of Pediatric Pulmonary, University of Michigan Medical Center, Ann Arbor, MI 48109
Bacterial pneumonia is a leading cause of morbidity and mortality in the U.S. An effective innate immune response is critical for the clearance of bacteria from the lungs. IL-12, a key T1 cytokine in innate immunity, signals through STAT4. Thus, understanding how STAT4 mediates pulmonary immune responses against bacterial pathogens will have important implications for the development of rational immunotherapy targeted at augmenting innate immunity. We intratracheally administered Klebsiella pneumoniae to wild-type BALB/c and STAT4 knockout (STAT4–/–) mice. Compared with wild-type controls, STAT4–/– mice had decreased survival following intratracheal Klebsiella administration, which was associated with a higher lung and blood bacterial burden. STAT4–/– animals also displayed impaired pulmonary IFN-
production and decreased levels of proinflammatory cytokines, including the ELR– CXC chemokines IFN--inducible protein-10 and monokine induced by IFN-. Although total lung leukocyte populations were similar between STAT4–/– and wild-type animals following infection, alveolar macrophages isolated from infected STAT4–/– mice had decreased production of proinflammatory cytokines, including IFN-, compared with infected wild-type mice. The intrapulmonary overexpression of IFN- concomitant with the systemic administration of IFN- partially reversed the immune deficits observed in STAT4–/– mice, resulting in improved bacterial clearance from the blood. Collectively, these studies demonstrate that STAT4 is required for the generation of an effective innate host defense against bacterial pathogens of the lung.
This article has been cited by other articles:
|
|
 |
|
  S. Cai, S. Batra, L. Shen, N. Wakamatsu, and S. Jeyaseelan Both TRIF- and MyD88-Dependent Signaling Contribute to Host Defense against Pulmonary Klebsiella Infection J. Immunol., November 15, 2009; 183(10): 6629 - 6638. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lau, V. von Dossow, M. Sander, M. MacGuill, N. Lanzke, and C. Spies Alcohol Use Disorder and Perioperative Immune Dysfunction Anesth. Analg., March 1, 2009; 108(3): 916 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. K. R. Karaolis, M. W. Newstead, X. Zeng, M. Hyodo, Y. Hayakawa, U. Bhan, H. Liang, and T. J. Standiford Cyclic Di-GMP Stimulates Protective Innate Immunity in Bacterial Pneumonia Infect. Immun., October 1, 2007; 75(10): 4942 - 4950. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Maeda, V. Dave, and J. A. Whitsett Transcriptional Control of Lung Morphogenesis Physiol Rev, January 1, 2007; 87(1): 219 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Jeyaseelan, S. K. Young, M. Yamamoto, P. G. Arndt, S. Akira, J. K. Kolls, and G. S. Worthen Toll/IL-1R Domain-Containing Adaptor Protein (TIRAP) Is a Critical Mediator of Antibacterial Defense in the Lung against Klebsiella pneumoniae but Not Pseudomonas aeruginosa J. Immunol., July 1, 2006; 177(1): 538 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zeng, T. A. Moore, M. W. Newstead, J. C. Deng, S. L. Kunkel, A. D. Luster, and T. J. Standiford Interferon-Inducible Protein 10, but Not Monokine Induced by Gamma Interferon, Promotes Protective Type 1 Immunity in Murine Klebsiella pneumoniae Pneumonia Infect. Immun., December 1, 2005; 73(12): 8226 - 8236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. I. Happel, P. J. Dubin, M. Zheng, N. Ghilardi, C. Lockhart, L. J. Quinton, A. R. Odden, J. E. Shellito, G. J. Bagby, S. Nelson, et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae J. Exp. Med., September 19, 2005; 202(6): 761 - 769. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
